Commission Implementing Regulation (EU) 2022/1226 of 14 July 2022 granting a Union authorisation for the single biocidal product ‘Bioquell HPV-AQ’ (Text with EEA relevance)
Commission Implementing Regulation (EU) 2022/1226of 14 July 2022granting a Union authorisation for the single biocidal product Bioquell HPV-AQ(Text with EEA relevance)THE EUROPEAN COMMISSION,Having regard to the Treaty on the Functioning of the European Union,Having regard to Regulation (EU) No 528/2012 of the European Parliament and of the Council of 22 May 2012 concerning the making available on the market and use of biocidal productsOJ L 167, 27.6.2012, p. 1., and in particular the first subparagraph of Article 44(5) thereof,Whereas:(1)On 19 January 2017, Ecolab Deutschland GmbH submitted an application, in accordance with Article 43(1) of Regulation (EU) No 528/2012, for authorisation of a single biocidal product named "Bioquell HPV-AQ" of product-types 2, 3 and 4 as described in Annex V to that Regulation, providing written confirmation that the competent authority of the Netherlands had agreed to evaluate the application. The application was recorded under case number BC-ML029042-45 in the Register for Biocidal Products.(2)"Bioquell HPV-AQ" contains hydrogen peroxide as the active substance, which is included in the Union list of approved active substances referred to in Article 9(2) of Regulation (EU) No 528/2012 for product-types 2, 3 and 4.(3)On 29 March 2021, the evaluating competent authority submitted, in accordance with Article 44(1) of Regulation (EU) No 528/2012, an assessment report and the conclusions of its evaluation to the European Chemicals Agency ("the Agency").(4)On 4 November 2021, the Agency submitted to the Commission an opinionECHA opinion of 13 October 2021 on the Union authorisation of "Bioquell HPV-AQ" (ECHA/BPC/296/2021), https://echa.europa.eu/bpc-opinions-on-union-authorisation, the draft summary of the biocidal product characteristics ("SPC") of "Bioquell HPV-AQ" and the final assessment report on the single biocidal product in accordance with Article 44(3) of Regulation (EU) No 528/2012.(5)The opinion concludes that the biocidal product "Bioquell HPV-AQ" is eligible for Union authorisation in accordance with Article 42(1) of that Regulation and that, subject to compliance with the draft SPC, it meets the conditions laid down in Article 19(1) of that Regulation.(6)On 25 November 2021, the Agency transmitted to the Commission the draft SPC in all the official languages of the Union in accordance with Article 44(4) of Regulation (EU) No 528/2012.(7)The Commission concurs with the opinion of the Agency and considers it therefore appropriate to grant a Union authorisation for "Bioquell HPV-AQ".(8)The measures provided for in this Regulation are in accordance with the opinion of the Standing Committee on Biocidal Products,HAS ADOPTED THIS REGULATION: